These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 18760341

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Distribution of nimodipine in brain following intranasal administration in rats.
    Zhang QZ, Jiang XG, Wu CH.
    Acta Pharmacol Sin; 2004 Apr; 25(4):522-7. PubMed ID: 15066224
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain.
    Zhang Q, Jiang X, Jiang W, Lu W, Su L, Shi Z.
    Int J Pharm; 2004 May 04; 275(1-2):85-96. PubMed ID: 15081140
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic behavior of huperzine A in plasma and cerebrospinal fluid after intranasal administration in rats.
    Wang Q, Chen G.
    Biopharm Drug Dispos; 2009 Dec 04; 30(9):551-5. PubMed ID: 19780094
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Huperzine A in rat plasma and CSF following intranasal administration.
    Yue P, Tao T, Zhao Y, Ren J, Chai X.
    Int J Pharm; 2007 Jun 07; 337(1-2):127-32. PubMed ID: 17241758
    [Abstract] [Full Text] [Related]

  • 14. Preparation of lorazepam-loaded microemulsions for intranasal delivery and its pharmacokinetics.
    Yao J, Hou L, Zhou JP, Zhang ZQ, Sun L.
    Pharmazie; 2009 Oct 07; 64(10):642-7. PubMed ID: 19947165
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of the distribution of breviscapine in the brain by different administration routes].
    Shi SL, Xu LY, Wu JJ, Li CY, Ge WH, Dai WY.
    Yao Xue Xue Bao; 2009 May 07; 44(5):515-8. PubMed ID: 19618729
    [Abstract] [Full Text] [Related]

  • 16. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.
    Thorne RG, Pronk GJ, Padmanabhan V, Frey WH.
    Neuroscience; 2004 May 07; 127(2):481-96. PubMed ID: 15262337
    [Abstract] [Full Text] [Related]

  • 17. Direct transport of VEGF from the nasal cavity to brain.
    Yang JP, Liu HJ, Cheng SM, Wang ZL, Cheng X, Yu HX, Liu XF.
    Neurosci Lett; 2009 Jan 09; 449(2):108-11. PubMed ID: 18996442
    [Abstract] [Full Text] [Related]

  • 18. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
    Khan S, Patil K, Yeole P, Gaikwad R.
    J Pharm Pharmacol; 2009 May 09; 61(5):669-75. PubMed ID: 19406007
    [Abstract] [Full Text] [Related]

  • 19. Brain distribution of ribavirin after intranasal administration.
    Colombo G, Lorenzini L, Zironi E, Galligioni V, Sonvico F, Balducci AG, Pagliuca G, Giuliani A, Calzà L, Scagliarini A.
    Antiviral Res; 2011 Dec 09; 92(3):408-14. PubMed ID: 22001322
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.